Reason for hospitalisation | Number of patients (percentage) |
---|---|
Active SLE | 55 (43) |
Newly diagnosed SLE | 29 (22.6) |
Known SLE | 26 (20.3) |
Types of flare (n) | |
Haematological (31) | |
Mucocutaneous (22) | |
Articular (18) | |
Renal (17) | |
Serositis (9) | |
Neuropsychiatric (3) | |
Assessment of the disease | 34 (26.5) |
Infection | 12 (9.4) |
Pneumonia (5) | |
Bacterial arthritis (salmonella) (2) | |
Urinary tract infection (2) | |
Cellulitis (2) | |
Brucellosis (1) | |
Associated autoimmune diseases | 8 (6.3) |
Inflammatory myositis (4) | |
Autoimmune thyroiditis (1) | |
Systemic sclerosis (1) | |
Pernicious anaemia (1) | |
Autoimmune hepatitis (1) | |
Adverse drug reaction | 4 (3.1) |
Anticoagulant related bleeding (2) | |
Hydroxychloroquine induced retinopathy (1) | |
Amennorhea (1) | |
Thromboembolic events | 2 (1.5) |
Pulmonary embolism (1) | |
Cerebral venous thrombosis (1) | |
Pregnancy | 2 (1.5) |
Others | 11 (8.6) |
Intravenous infusions of rituximab (3) | |
Poorly controlled diabetes mellitus (2) | |
Poorly controlled hypertension (2) | |
Liver function abnormalities (1) | |
Hypereosinophilia (1) | |
Hypogammaglobulinemia (1) | |
Seizures (1) |
SLE, systemic lupus erythematosus.